Enchondromas are benign, solitary bone tumors originating from hyaline cartilage, that are usually located in the upper and lower extremities. They are equally distributed in both genders and in all age groups. 40 -65% of enchondromal cases are found in metacarpal bones. The most common involvement is the proximal phalanx, metacarpal bone, and distal phalanx. Involvement of distal phalanx in patients with enchondroma is rare. Our aim in this study was to investigate the pre operative neutrophil count, white blood cell count, red cell distribution width, mean corpu scular volume, platelet count, hemoglobin, hematocrit and NLR values, and make a comparison with a control group. The most commonly involved sites are also investigated in the patient group. This retrospective study investigated the preoperative WBC, neutrophil, lymphocyte, RDW, MCV, NLR values in 20 patients and 20 controls, and compared the frequency of the involved sites among patients with enchondroma. WBC, neutrophil count, MCV, RDW were not found statistically significant. NLR ratios were different be tween groups, but not statistically significant. Involvement of the proximal phalanx was statistically significantly higher (p<0.05). This is the first study investigating the pre-operative RDW, MCV, NLR, PLT, Hgb, Hct and WBC in patients with enchondroma. Although there is no statistically significant difference when these results are compared we suggest that they should be studied in larger groups and in clinical tests, so that the malignancy potential may be predicted.
1. Cabay RJ, Reddy V, David O et al: Cytologic features of primary chondroid tumors of bone in crush preparations.Diagn Cytopathol 2008; 36: 758-761.
2. Walden MJ, Murphey MD, Vidal JA. Incidental enchondromas of the knee. AJR Am J Roentgenol 2008; 190: 1611-1615.
3. Van der Geest IC, de Valk MH, de Rooy JW, et al: Oncological and functional results of cryosurgical therapy of enchondromas and chondrosarcomas grade 1. J Surg Oncol 2008; 98: 421-426.
4. Ojeda Thies C, Bonsfills N, Albinana J. Solitary epiphyseal enchondroma of the proximal femur in a 23 month old girl. J Pediatr Orthop 2008; 28: 565-568.
5. Adaş M, Yurdoğlu HC, Tombul M, et al: Femur alt uç enkondromlarının küretaj ve kemik çimentosu ile tedavi sonuçları. Acta Orthop Traumatol Turc 2007; 41: 380386.
6. Kaya T. Kas iskelet - yumuşak doku radyolojisi. 1.baskı. Bursa: Nobel & Güneş Tıp Kitabevi; 2008.s.509.
7. Malizos KN, Gelalis ID, Ioachim EE, et al: Pathologic fracture of the scaphoid due to enchondroma:treatment with vascularized bone grafting. Report of a case.J Hand Surg [Am] 1998; 23: 334-337.
8. Canovas F, Nicolau F, Bonnel F. Avulsion of the flexor digitorum profundus tendon associated with a chondroma of the distal phalanx. J Hand Surg 1998; 23: 130-131.
9. Shimizu K, Kotoura Y, Nishijima N, et al: Enchondroma of the distal phalanx of the hand. J Bone Joint Surg 1997; 79: 898-900.
10. Lucas DR, Bridge JA. Chondromas: enchondroma, periosteal chondroma, and enchondromatosis. In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002. P.237-240.
11. Resnick D, Kyriakos M, Greenway GD. Tumors and tumor-like lesions of bone: Imaging and pathology of specific lesions. In: Resnick D, editor. Diagnosis of Bone and Joint Disorders, 3rd ed. Philadelphia: WB Saunders; 1995. P.3629- 3647.
12. Murphey MD, Flemming DJ, Boyea SR, et al. Enchondroma versus chondrosarcoma in the appendicular skeleton: differentiating situations. Radiographics 1998; 18: 1213-1237.
13. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
14. Paramanathan A, Saxena A, Morris DL. A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol 2014; 23: 31-39.
15. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867.
16. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001; 357: 539- 545.
17. Mantovani A, Allavena P, Sica A, et al: Cancerrelated inflammation. Nature 2008; 454: 436-444.
18. Kusumanto YH, Dam WA, Hospers GA, et al: Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003; 6: 283-287.
19. Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotheraphy in advanced rectal cancer. BMC Cancer 2011; 11: 64.
20. Ogino S, Nosho K, Irahara N, et al: Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and cpg island methylator phenotype. Clin Cancer Res 2009; 15: 6412-6420.
21. Mahmoud SM, Paish EC, Powe Dg et al: Tumorinfiltrating CD8+lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011; 29: 1949-1955.
22. Clemente CG, Mihm MC Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996; 77: 1303-1310.
23. Ertas IE, Gungorduk K, Akman L, et al: Can preoperative neutrophil: lymphocyte and platelet: lymphocyte ratios be used as predictive markers for lymph node metastasis in squamous cell carcinoma of the vulva? Eur J Obstet Gynecol Reprod Biol 2013; 171: 138-142.
24. Teramukai S, Kitano T, Kishida Y, et al: Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 2009; 45: 1950-1958.
25. Maltoni M, Pirovano M, Nanni O, et al : Biological indices predictive of survival in 519 Italian terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 1997; 13: 1-9.
26. Mallappa S, Sinha A, Gupta S, et al: Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis 2013; 15: 323-328.
27. Horne BD, Anderson JL, John JM, et al: Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 10: 1638-1643.
28. Zahorec R. Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102: 5-14.
29. Kacan T, Babacan NA, Seker M, et al: Could the neutrophil to lymphocyte ratio be a poor prognostic factor for non small cell lung cancers? Asian Pac J Cancer Prev 2014; 15: 2089-2094.
30. Li J, Jiang R, Liu WS, et al: A large cohort study reveals the association of elevated peripheral blood lymphocyte-to-monocyte ratio with favorable prognosis in nasopharyngeal carcinoma. Plos One 2013; 8: e83069.
31. Fu SJ, Shen SL, Li SQ, et al: Prognostic value of preoperative peripheral neutrophilto-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy. Med Oncol 2013; 30: 721.
32. Kum RO, Ozcan M, Baklaci D, et al: Elevated neutrophil-to-lymphocyte ratio in squamous cell carcinoma of larynx compared to benign and precancerous laryngeal lesions. Asian Pac J Cancer Prev 2014; 15: 7351-7355.
33. Goh BK, Chok AY, Allen JC Jr, et al: Blood neutrophil-to-lymphocyte and platelettolymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors. Surgery 2016; 159: 1146-1156.
34. Han S, Liu Y, Li Q, et al: Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma. BMC Cancer 2015; 15: 617.
35. Suppan C, Bjelic-Radisic V, La Garde M, et al: Neutrophil/lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy. BMC Cancer 2015; 15: 1027.
36. Chen ZY, Raghav K, Lieu CH, et al: Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer 2015; 112: 1088-1097.
37. Huang W, Huang J, Liu Q, et al: Neutrophillymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy. Clin Endocrinol (Oxf) 2015; 82: 229-233.
38. Wang S, Zhang Z, Fang F, et al: The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett 2011; 2: 735-740.